HealthSeptember 4, 2026
zilganersen
ZIL-guh-nur-sen
Definition
An antisense oligonucleotide drug developed by Ionis Pharmaceuticals to treat the underlying cause of the rare neurodegenerative disorder known as Alexander disease.
Etymology
The name is a modern pharmaceutical coinage following standard naming conventions for drugs, where the suffix '-ersen' identifies it as an antisense oligonucleotide.
In the news
Zilganersen is introduced as the specific therapeutic agent that has received FDA approval as a disease-modifying treatment for patients with Alexander disease.
Ionis nets Zanvastro US approval in first for Alexander disease
Read the full article ↗Pharmaceutical Technology